Hogan Lovells advises Labcorp on US$575 million acquisition of Personal Genome Diagnostics

Press releases | 27 December 2021

Washington, D.C., 27 December, 2021 - Global law firm Hogan Lovells served as lead transaction counsel for Labcorp, a leading life sciences company, in its acquisition of Personal Genome Diagnostics Inc., a provider of comprehensive liquid biopsy and tissue-based genomic products and services. Read more on the US$575 million deal, which was announced December 23, here.  

The Hogan Lovells M&A team was led by partners Michael Silver in New York and Allen Hicks, in Washington, D.C., with law clerk Maggie Dombrowsky (D.C.), and associates Jason Sloan (New York) and Eli Mekonen (D.C.).  

Health regulatory advice was provided by senior counsel Helen Trilling, counsel Brooke Bumpers and senior associate Laura Hunter (all D.C.), with partner Randy Prebula (D.C.) and senior associate Erkang Ai (Philadelphia) providing FDA guidance. Other team members included partner Carin Carithers (D.C.) and associate Bothwell Graham who advised on benefits, partner Mike DeLarco and senior associate David Mitchell (both NY) who advised on employment, partner Scott Loughlin (D.C.) and senior associate Khaled Mowad (NY) who advised on privacy, partner Aleksandar Dukic and senior associate Patrick de Lapérouse (both D.C.) who advised on international trade, partner Jasper Howard and senior associate Caitlin Piper (both D.C.) who advised on tax, and partners Leigh Oliver and Lauren Battaglia and counsel Robert Baldwin III (all D.C.) who advised on antitrust.